Prm-mass spectrometry

Show results for

Proteomics (520)
Unknown (195)
Metabolomics (40)
Transcriptomics (2)
Genomics (2)
Other (1)

Organisms

Homo sapiens (54)
Mus musculus (11)
Rattus norvegicus (3)
Gallus gallus (2)
Tachysurus fulvidraco (2)
Tachysurus fulvidraco x Tachysurus vachelli (2)
Tachysurus vachellii (2)
Canis lupus familiaris (2)
Bos taurus (2)
Human betaherpesvirus 5 (2)
Apis mellifera (1)
Bambusa grandis (1)
Bambusa pervariabilis (1)
Capra hircus (1)
Sorghum bicolor x Saccharum hybrid cultivar (1)
Staphylococcus aureus (1)
Tribolium castaneum (1)
Yersinia pestis CO92 (1)
Norwalk virus (1)
Bacillus thuringiensis (1)
Bacillus thuringiensis serovar aizawai (1)
Bacillus thuringiensis serovar israelensis (1)
Bacillus thuringiensis serovar kurstaki (1)
Candidatus Kinetoplastidibacterium blastocrithidiae (ex Strigomonas culicis) (1)
Danio rerio (1)
Escherichia coli (1)
Human alphaherpesvirus 1 (1)
Human gammaherpesvirus 8 (1)
Macaca fascicularis (1)
Murine norovirus (1)

Organisms

Homo sapiens (1)

Repository

pride (413)
MetaboLights (39)
PanoramaPublic (35)
iProX (30)
MassIVE (27)
jPOST (16)
biostudies-arrayexpress (2)
geo (1)
GNPS (1)
ENA (1)

Tissue

Cell culture (70)
Brain (30)
Blood plasma (19)
Epithelial cell (19)
Blood serum (18)
Liver (17)
Lung (12)
Cerebrospinal fluid (11)
Permanent cell line cell (11)
Blood (10)
Fibroblast (10)
Kidney (10)
Plant cell (9)
Blood cell (8)
Spleen (8)
B cell (7)
Colon (7)
Macrophage (7)
Whole body (7)
Embryonic stem cell (6)
HeLa cell (6)
Urine (6)
Breast (5)
Embryo (5)
Primary cell (5)
Saliva (4)
T cell (4)
Testis (4)
Bronchoalveolar lavage (3)
Heart (3)

Disease

Breast cancer (14)
Disease free (13)
Colon cancer (11)
COVID-19 (7)
Parkinson's disease (7)
Acute leukemia (6)
Malignant neoplasm of ovary (6)
Alzheimer's disease (5)
Severe acute respiratory syndrome (5)
Cardiovascular system disease (4)
Brain cancer (3)
Cervix carcinoma (3)
Inflammatory bowel disease (3)
Multiple myeloma (3)
Crohn's disease (2)
Glioblastoma (2)
Liver cirrhosis (2)
Lung adenocarcinoma (2)
Multiple sclerosis (2)
Non-alcoholic steatohepatitis (2)
Non-small cell lung carcinoma (2)
Pancreatic cancer (2)
Tuberculosis (2)
Ulcerative colitis (2)
Alzheimer's disease 4 (1)
Coronavirus infectious disease (1)
Glanzmann's thrombasthenia (1)
Huntington Disease (1)
Lewy body dementia (1)
Pediatric onset (1)

Technology Type

Mass Spectrometry (413)
SRM/MRM (220)
Shotgun proteomics (164)
Bottom-up proteomics (70)
Affinity purification coupled with mass spectrometry proteomics (48)
Data-dependent acquisition (42)
Mass spectrometry (25)
Data-independent acquisition (17)
Gel-based experiment (17)
Mass spectrometry assay (14)
SWATH MS (10)
Top-down proteomics (6)
Immunopeptidomics (5)
Chemical cross-linking coupled with mass spectrometry proteomics (3)
All-ion fragmentation (2)
Glycoproteomics (2)
Affinity proteomics (1)
MSE (1)
Proteogenomics (1)

Instrument Platform

Liquid Chromatography MS - positive - reverse phase (12)
Liquid Chromatography MS - negative - reverse phase (8)
Q Exactive Plus (5)
Orbitrap Fusion (5)
Q Exactive (5)
Liquid Chromatography MS - alternating - hilic (5)
Liquid Chromatography MS - negative - hilic (5)
Orbitrap Exploris 480 (4)
Orbitrap Fusion Lumos (4)
Liquid Chromatography MS - alternating - reverse-phase (4)
Liquid Chromatography MS - positive - hilic (3)
Direct infusion MS - positive (2)
Liquid Chromatography MS - (2)
Gas Chromatography MS - positive (2)
Liquid Chromatography MS - negative - reverse-phase (2)
LTQ Orbitrap Elite (1)
LTQ Orbitrap XL (1)
LTQ Velos (1)
LTQ XL (1)
Orbitrap Astral (1)
Orbitrap Eclipse (1)
Orbitrap Fusion ETD (1)
Q Exactive HF (1)
Q Exactive HF-X (1)
Stellar (1)
TSQ Altis (1)
TSQ Vantage (1)
TimsTOF (1)
TripleTOF 5600 (1)
Xevo G2-S QTof (1)

Publication Date

2022 (74)
2026 (72)
2023 (70)
2025 (67)
2021 (67)
2024 (66)
2020 (49)
2019 (24)
2018 (22)
2017 (14)
2016 (7)
2015 (4)
2014 (1)
2013 (1)
2010 (1)

CHEBI ID

CHEBI:16335 (6)
CHEBI:16704 (6)
CHEBI:17596 (6)
CHEBI:20794 (5)
CHEBI:20129 (5)
CHEBI:16020 (5)
CHEBI:17562 (4)
CHEBI:16750 (4)
CHEBI:30769 (4)
CHEBI:19688 (3)
CHEBI:178092 (3)
CHEBI:178091 (3)
CHEBI:19068 (3)
CHEBI:68467 (3)
CHEBI:19228 (3)
CHEBI:19227 (3)
CHEBI:20607 (3)
CHEBI:19229 (3)
CHEBI:19702 (3)
CHEBI:19065 (3)
CHEBI:21891 (3)
CHEBI:7676 (3)
CHEBI:16113 (3)
CHEBI:16040 (3)
CHEBI:19062 (3)
CHEBI:17802 (3)
CHEBI:89487 (3)
CHEBI:17858 (3)
CHEBI:69426 (3)
CHEBI:28300 (3)

Metabolite Name

Adenosine (6)
1-methyladenosine (5)
3-methylcytidine (5)
Guanosine (5)
Uridine (5)
7-methylguanosine (4)
1-methylinosine (4)
Cytosine (4)
Methionine (4)
Tryptophan (4)
2-methyladenosine (3)
8-methyladenosine (3)
6-methyladenosine (3)
3-methylpseudouridine (3)
1-methylpseudouridine (3)
5-methyluridine (3)
3-methyluridine (3)
4-methylcytidine (3)
2'-O-methyluridine (3)
5-methylcytidine (3)
2'-O-methylinosine (3)
2'-O-methylcytidine (3)
Uridine (3)
2'-O-methylguanosine (3)
Valine (3)
Inosine (3)
(-)-Epigallocatechin (3)
Ornithine (3)
Acetylcholine (3)
Choline (3)

First Public Date

2022 (1)

Modification

2x(15)N labeled L-lysine (3)
4x(15)N labeled L-arginine (3)
N6 (3)
4-tetrahydrothiazine-3-carboxylic acid (2)
1x(15)N labeled L-leucine (1)
N6-dimethyl-L-lysine (1)

Study type

Transcription profiling by array (1)
RNA-seq of coding RNA (1)

Release Date

2022 (30)
2024 (26)
2021 (26)
2023 (25)
2020 (24)
2025 (23)
2019 (12)
2018 (11)
2017 (9)
2026 (4)
2014 (2)
2013 (2)
2016 (2)
2015 (1)

Lab affiliation

Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN 55905, USA (4)
Institute of Molecular Systems Biology, ETH Zurich, 8093 Zurich, Switzerland Faculty of Science, University of Zurich, Zurich, Switzerland (4)
Baylor College of Medicine (3)
Carnegie Mass Spectrometry Facility, Carnegie Institution for Science at Stanford (3)
Environmental Toxicology Graduate Program and Department of Chemistry, University of California, Riverside, California 92521, United States (3)
Medizinisches Proteom-Center, Medical Faculty, Ruhr-University Bochum, Bochum, Germany (3)
Washington University in St. Louis (3)
Analytical Chemistry, Department of Chemistry – BMC and Science for Life Laboratory, Uppsala University, Box 599, 751 24 Uppsala, Sweden (2)
Biomolecular Mass Spectrometry and Proteomics, Bijvoet Center for Biomolecular Research and Utrecht Institute for Pharmaceutical Sciences, Science4Life, University of Utrecht, Padualaan 8, 3584 CH Utrecht, The Netherlands (2)
Center for Immunity and Immunotherapies, Seattle Children's Research Institute. Department of Pediatrics, University of Washington. Seattle, WA USA (2)
Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center (2)
Department of Laboratory Medicine and Pathology, Mayo Clinic (2)
Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel (2)
Department of Molecular Physiology and Biological Physics, University of Virginia, Charlottesville, VA USA (2)
Department of Systems Immunology, Weizmann Institute of Science, Rehovot, Israel (2)
Head of Laboratory of Neuro-Oncology Clinical & Cancer Proteomics Erasmus MC the Netherlands (2)
Head of Laboratory of Neuro-Oncology, Neurology, Clinical & Cancer Proteomics (2)
Head of Scientific Archeology Unit, Weizmann Institute of Science (2)
Head, Dept of Immunology, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Ullernchausséen 70, 0379 Oslo, Norway (2)
Institute of Biochemistry (2)
Institute of Biochemistry (ETHZ) (2)
Institute of Biophysics, Chinese Academy of Sciences (2)
JGU University Mainz (2)
Lab. Neuro-Oncology and Clinical Cancer Proteomics, Erasmus Medical Center, the Netherlands (2)
Laboratoire de Spectrometrie de Masse Proteomique Institut Curie PSL Research University (2)
Laboratory of Protein Metabolism, Tokyo Metropolitan Institute of Medical Science (2)
Lanzhou Veterinary Research Institute (2)
Mass Spectrometry & Proteomics Core Facility (MSPCF) Institute for Research in Biomedicine (IRB Barcelona) Barcelona Institute of Science and Technology (BIST) C/ Baldiri Reixac, 10-12 08028 Barcelona - Spain. (2)
Moffitt Cancer Center (2)
Novo Nordisk Foundation Center for Protein Research (CPR), University of Copenhagen, Copenhagen, Denmark. (2)

Previous page
1 / 76
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 76
Next page

Sort by:

Relevance

Page size

Liquid Chromatography-Mass Spectrometry Quantification of Phytochemicals in Withania somnifera Using Data-Dependent Acquisition, Multiple-Reaction-Monitoring, and Parallel-Reaction-Monitoring with an Inclusion List

Characterization of botanical extracts by mass spectrometry-based metabolomics analysis helps in determining the phytochemical composition that underlies their bioactivity and potential health benefits, while also supporting reproducibility of effects in clinical trials. The quantification of sev...

2024-07-10 | MTBLS10418 | MetaboLights

Authentication of pork in meat mixtures using PRM mass spectrometry of myosin peptides.

Not available

S-EPMC9078958 | biostudies-literature

Liquid Chromatography-High-Resolution Mass Spectrometry-Based In Vitro Toxicometabolomics of the Synthetic Cathinones 4-MPD and 4-MEAP in Pooled Human Liver Microsomes

Synthetic cathinones belong to the most often seized new psychoactive substances on an international level. This study investigated the toxicometabolomics, particularly the in vitro metabolism of 2-(methylamino)-1-(4-methylphenyl)-1-pentanone (4-MPD) and 2-(ethylamino)-1-(4-methylphenyl)-1-pentanone...

2023-11-28 | MTBLS2218 | MetaboLights

QuickProt: A bioinformatics and visualization tool for DIA and PRM mass spectrometry-based proteomics datasets.

Not available

S-EPMC11974799 | biostudies-literature

High-performance nano-flow liquid chromatography column combined with high- and low-collision energy data-independent acquisition enables targeted and discovery identification of modified ribonucleotides by mass spectrometry (Data-independent acquisition)

Over 170 post-transcriptional RNA modifications have been described and are common in all kingdoms of life. These modifications range from methylation to complex chemical structures, with methylation being the most abundant. RNA modifications play a key role in RNA folding and function and their ...

2023-10-26 | MTBLS2959 | MetaboLights

2023-10-26 | MTBLS2497 | MetaboLights

FRACPRED-2D-PRM: A Fraction Prediction Algorithm-Assisted 2D Liquid Chromatography-Based Parallel Reaction Monitoring-Mass Spectrometry Approach for Measuring Low-Abundance Proteins in Human Plasma.

Not available

S-EPMC7744362 | biostudies-literature

Data-independent Acquisition - Parallel Reaction Monitoring (DIA-PRM) Acquisition Reveals Alteration of Lysosomal Hydrolases in a Mouse Model of Metachromatic Leukodystrophy

For the reproducible analysis of peptides by mass spectrometry-based proteomics, data-independent acquisition (DIA) and parallel/multiple reaction monitoring (PRM/MRM) deliver unrivalled performance with respect to sensitivity and reproducibility. Both approaches come, however, with distinct advanta...

ORGANISM(S): Mus musculus (Mouse)

2025-05-07 | PXD052313 | Pride

Identification of serum biomarkers to predict pemetrexed/platinum chemotherapy efficacy for advanced lung adenocarcinoma patients by data-independent acquisition (DIA) mass spectrometry analysis with parallel reaction monitoring (PRM) verification.

Not available

S-EPMC7947410 | biostudies-literature

Identification and relative quantification of hFSH glycoforms in women sera by PRM MS based approach.

This study presents an alternative preliminary strategy to identify and quantify serum hFSH glycoforms based on immunopurification assay and mass spectrometry (MS) using parallel reaction monitoring (PRM) analysis. In this study, we provide MS-PRM data acquisition method for hFSH glycopeptides ident...

ORGANISM(S): Homo sapiens (Human)

2021-06-15 | PXD025585 | Pride

Prm-mass spectrometry fsh glycosylation

Previous page
1 / 76
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 76
Next page

Sort by:

Relevance

Page size

760 Results

Show results for

Organisms

Organisms

Repository

Tissue

Disease

Technology Type

Instrument Platform

Publication Date

CHEBI ID

Metabolite Name

First Public Date

Modification

Study type

Release Date

Lab affiliation

OmicsDI is part of the ELIXIR infrastructure

Tweets